GlassScriptPhysician profile
Megan Frey
NPI 1144757618
$4,717.12
in general payments reported to CMS, 2019-2025
15 companies · $683 in 2025
The $683 reported for 2025 was more than what 79% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $406 · 2022: $570 · 2023: $2,495 · 2024: $564 · 2025: $683.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,323 · Travel and Lodging: $1,419.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,322.71 |
| Travel and Lodging | $1,419.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,968.78 | 2021-2025 | General - Therapies, Farapulse, Lux-Dx Insertable Cardiac Monitor |
| Abbott Laboratories | $794.75 | 2021-2025 | Ensite |
| Medtronic, INC. | $340.17 | 2024-2025 | Pulseselect, Affera Mapping System, Micra |
| Novartis Pharmaceuticals Corporation | $132.15 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $86.31 | 2022-2023 | Verquvo |
| Janssen Pharmaceuticals, INC | $73.76 | 2022 | |
| Kestra Medical Technology Services, INC. | $61.92 | 2023-2025 | Assure Wcd |
| Biotronik INC. | $56.68 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $54.29 | 2023 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.95 | 2022 | |
| Pfizer INC. | $28.75 | 2022-2023 | |
| Amgen INC. | $26.74 | 2022 | |
| Philips North America LLC | $25.19 | 2025 | Lm Undivided |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.60 | 2023 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $13.08 | 2023 | Opsumit, Uptravi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Frey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.